— Know what they know.
Not Investment Advice
Also trades as: LLY.TO (TSX) · $vol 2M · LLY.DE (XETRA) · $vol 2M · LLY.SW (SIX) · $vol 0M

LLY NYSE

Eli Lilly and Company
1W: +3.1% 1M: +8.1% 3M: +4.8% YTD: +18.6% 1Y: +56.0% 3Y: +120.0% 5Y: +457.4%
$1,281.91
+2.77 (+0.22%)
After Hours: $1282.55 (+0.64, +0.05%)
Weekly Expected Move ±4.4%
$1162 $1218 $1273 $1329 $1385
NYSE · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 82 · $1.20T mcap · 848M float · 0.308% daily turnover · Short 48% of daily vol
Credit Risk of going bust: lower than 84% of companies Debt: 4.4% of company value Bonds: $1.28B held by 465 funds, 44 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $5.05 (down 99.6%), Eli Lilly and Company would be worth roughly what it owes.
Total debt $54.91B against a stock market value of $1.20T.
Distance to default 10.86 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $30.98B (short-term plus half of long-term), stock volatility 34.6%; Altman Z 8.56. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Cash Flow Trends

Operating Cash Flow
$16.8B +90.7% ▲
5Y CAGR: +20.9%
Capital Expenditures
$7.8B +6.7% ▲
5Y CAGR: +31.0%
Free Cash Flow
$9.0B +2065.6% ▲
5Y CAGR: +14.9%
Dividends Paid
$5.4B -15.0% ▼
Buybacks
$4.1B -64.3% ▼
Net Change in Cash
$4.0B +789.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$5.6B$6.2B$5.2B$10.6B$20.6B
Depreciation & Amort.$1.5B$1.5B$1.5B$1.8B$2.0B
Stock-Based Comp.$343M$371M$628M$646M$626M
Change in Working Capital-$1.0B-$800K-$3.1B-$5.4B-$8.1B
Other Non-Cash Items$1.7B$1.6B$2.2B$3.9B$3.4B
Operating Cash Flow$7.4B$7.6B$4.2B$8.8B$16.8B
— Investing Activities —
Capital Expenditures-$1.3B-$1.9B-$3.4B-$5.1B-$7.8B
Acquisitions (Net)-$747M-$327M-$1.0B-$948M-$661M
Investment Purchases-$1.0B-$708M-$829M-$776M-$645M
Investment Sales$847M$464M$700M$522M$964M
Other Investing-$644M-$1.3B-$2.5B-$3.0B-$2.8B
Investing Cash Flow-$2.9B-$3.8B-$7.2B-$9.3B-$11.0B
— Financing Activities —
Net Debt Issuance$501M-$62M$8.6B$8.9B$8.1B
Stock Repurchased-$1.2B-$1.5B-$750M-$2.5B-$4.1B
Dividends Paid-$3.1B-$3.5B-$4.1B-$4.7B-$5.4B
Other Financing-$296M-$309M-$335M-$491M-$772M
Financing Cash Flow-$4.1B-$5.4B$3.5B$1.2B-$2.2B
Net Change in Cash$161M-$1.8B$752M$450M$4.0B
Cash End of Period$3.8B$2.1B$2.8B$3.3B$7.3B
Free Cash Flow$5.4B$4.6B-$3.2B$414M$9.0B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms